Cite
HARVARD Citation
Saffo, S. et al. (2021). SGLT2 inhibitors in patients with cirrhosis and diabetes mellitus: A tertiary center cohort study and insights about a potential therapeutic target for portal hypertension. Journal of diabetes. 13 (3), pp. 265-269. [Online].